Thomas Jay Lowery
Direttore Tecnico/Scientifico/R&S presso Satellite Biosciences, Inc.
Profilo
Thomas Jay Lowery is currently the Chief Technology Officer at Satellite Biosciences, Inc. Previously, he worked as the Vice President-Diagnostics Research & Development at T2 Biosystems, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from the University of California, Berkeley.
Posizioni attive di Thomas Jay Lowery
| Società | Posizione | Inizio |
|---|---|---|
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Direttore Tecnico/Scientifico/R&S | 01/08/2020 |
Precedenti posizioni note di Thomas Jay Lowery
| Società | Posizione | Fine |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thomas Jay Lowery
| University of California, Berkeley | Doctorate Degree |
| Brigham Young University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Thomas Jay Lowery
